112 related articles for article (PubMed ID: 3689428)
1. Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation.
Peterson TC
Biochem Pharmacol; 1987 Nov; 36(22):3911-6. PubMed ID: 3689428
[TBL] [Abstract][Full Text] [Related]
2. Monocyte aryl hydrocarbon hydroxylase (AHH) activity mimics Kupffer cell and hepatocyte AHH activity in an animal model of liver disease.
Peterson TC; Williams CN; Malatjalian DA
Can J Physiol Pharmacol; 1991 Dec; 69(12):1797-803. PubMed ID: 1802352
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon hydroxylase activity in subpopulations of peripheral blood mononuclear cells.
Jett JR; Stobo JD; Moses HL
Cancer Res; 1978 Jul; 38(7):1979-82. PubMed ID: 306872
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of aryl hydrocarbon hydroxylase inducibility by aromatic hydrocarbons in monolayer-cultured hepatocytes from nonresponsive mouse strains.
Nemoto N; Sakurai J; Tazawa A; Ishikawa T
Cancer Res; 1990 Jun; 50(11):3226-30. PubMed ID: 1692256
[TBL] [Abstract][Full Text] [Related]
5. The role of heme oxygenase and aryl hydrocarbon hydroxylase in the protection by cysteamine from acetaminophen hepatotoxicity.
Peterson TC; Peterson MR; Williams CN
Toxicol Appl Pharmacol; 1989 Mar; 97(3):430-9. PubMed ID: 2609341
[TBL] [Abstract][Full Text] [Related]
6. Depression of peripheral blood monocyte aryl hydrocarbon hydroxylase activity in patients with liver disease: possible involvement of macrophage factors.
Peterson TC; Williams CN
Hepatology; 1987; 7(2):333-7. PubMed ID: 3557313
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of metabolic enzyme levels in macrophage populations of the F344 rat.
Germolec DR; Adams NH; Luster MI
Biochem Pharmacol; 1995 Oct; 50(9):1495-504. PubMed ID: 7503801
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic cysteamine treatment on mouse liver aryl hydrocarbon hydroxylase activity.
Peterson TC
Can J Physiol Pharmacol; 1988 Nov; 66(11):1433-6. PubMed ID: 3242778
[TBL] [Abstract][Full Text] [Related]
9. Effect of aging and other factors on monocyte aryl hydrocarbon hydroxylase activity.
Putnam AD; Peterson TC
Mech Ageing Dev; 1991 Sep; 60(1):61-74. PubMed ID: 1745065
[TBL] [Abstract][Full Text] [Related]
10. Altered activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and adrenalectomized diabetic rats.
Al-Turk WA; Stohs SJ; Roche EB
Pharmacology; 1981; 23(6):337-45. PubMed ID: 6975948
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytochromes P-450 in rat hepatoma cells. Analysis by monoclonal antibodies specific for cytochromes P-450 from rat liver induced by 3-methylcholanthrene or phenobarbital.
Wiebel FJ; Park SS; Kiefer F; Gelboin HV
Eur J Biochem; 1984 Dec; 145(3):455-62. PubMed ID: 6334605
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
Mason ME; Okey AB
Cancer Res; 1981 Jul; 41(7):2778-82. PubMed ID: 6265068
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of hepatic aryl hydrocarbon hydroxylase activity in feral winter flounder: relevance to carcinogenicity testing.
Bend JR; Foureman GL; Ben-Zvi Z; Albro PW
Natl Cancer Inst Monogr; 1984 May; 65():359-70. PubMed ID: 6462197
[TBL] [Abstract][Full Text] [Related]
14. Effects of phenobarbital and 3-methylcholanthrene pretreatment on size, sedimentation velocity, and mixed function oxygenase activity of rat hepatocytes.
Sweeney GD; Jones KG; Krestynski F
J Lab Clin Med; 1978 Mar; 91(3):444-54. PubMed ID: 415100
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication.
Peterson TC
Biochem Pharmacol; 1992 Mar; 43(5):1163-6. PubMed ID: 1554389
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of heme and drug metabolism in rat testis and prostate: response to cis-platinum and human chorionic gonadotropin.
Iscan M; Maines MD
J Pharmacol Exp Ther; 1990 Apr; 253(1):73-9. PubMed ID: 2329524
[TBL] [Abstract][Full Text] [Related]
17. Depression of cytochrome P-450-dependent drug biotransformation in hepatocytes after the activation of the reticuloendothelial system by dextran sulfate.
Peterson TC; Renton KW
J Pharmacol Exp Ther; 1984 Apr; 229(1):299-304. PubMed ID: 6200594
[TBL] [Abstract][Full Text] [Related]
18. Epidermal cell growth-dependent arylhydrocarbon-hydroxylase (AHH) activity in vitro.
Thiele B; Merk HF; Bonnekoh B; Mahrle G; Steigleder GK
Arch Dermatol Res; 1987; 279(8):521-3. PubMed ID: 3435181
[TBL] [Abstract][Full Text] [Related]
19. Flavone modulators of rat hepatic aryl hydrocarbon hydroxylase.
Friedman FK; West D; Sugimura T; Gelboin HV
Pharmacology; 1985; 31(4):203-7. PubMed ID: 4059325
[TBL] [Abstract][Full Text] [Related]
20. Role of the 4-5S binding protein in the induction of aryl hydrocarbon hydroxylase in the rat.
Harris M; Kamps C; Safe S
Carcinogenesis; 1988 Aug; 9(8):1475-9. PubMed ID: 3402044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
